Sage Therapeutics Inc Profit Margin (Quarterly)
Sage Therapeutics Inc Profit Margin (Quarterly) Chart
Sage Therapeutics Inc Historical Profit Margin (Quarterly) Data
|Data for this Date Range|
|June 30, 2018||-18.86%|
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Profit Margin
Profit margin represents the percentage of revenue that a company keeps as profit after accounting for fixed and variable costs. It is calculated by dividing net income by revenue. The profit margin is mainly used for internal comparisons, because acceptable profit margins vary between industries. In general, narrow profit margins indicate increased volatile earnings. For companies with significant fixed costs, wide profit margins reduce the risk that a decline in sales will cause a net profit loss.
Displayed as a percentage, profit margin can be thought as the amount of profit that a company keeps per dollar of revenue. For example, if a company has a profit margin of 43%, the company keeps $.43 of each dollar of revenue.
SAGE Profit Margin (Quarterly) Benchmarks
|Ionis Pharmaceuticals Inc||-3.14%|
|Alnylam Pharmaceuticals Inc||-11.86K%|
|United Therapeutics Corp||25.81%|
SAGE Profit Margin (Quarterly) Range, Past 5 Years
SAGE Profit Margin (Quarterly) Excel Add-In Codes
- Metric Code: profit_margin
- Latest data point: =YCP("SAGE", "profit_margin")
- Last 5 data points: =YCS("SAGE", "profit_margin", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
SA Breaking News 12/14 09:54 ET
Yahoo 12/14 07:00 ET
Yahoo 12/12 16:12 ET
Yahoo 12/10 03:56 ET
Business Wire 12/05 06:30 ET
Business Wire 11/21 06:30 ET
SA Breaking News 11/20 08:34 ET